Walleye Trading
BIB icon

Walleye Trading’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Walleye Trading’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-393
Closed -$27K – 4641
2018
Q3 		$27K Buy
+393
New +$25.7K ﹤0.01% 4756
2017
Q4 		– Sell
-299
Closed -$18 – 4344
2017
Q3 		$18 Buy
299
+177
+145% +$10.1K ﹤0.01% 3925
2017
Q2 		$7 Sell
122
-3,417
-97% -$167K ﹤0.01% 4293
2017
Q1 		$171 Buy
3,539
+3,204
+956% +$149K ﹤0.01% 3063
2016
Q4 		$13K Buy
335
+235
+235% +$10K ﹤0.01% 4218
2016
Q3 		$5K Buy
+100
New +$4.75K ﹤0.01% 4550

Other funds holding BIB

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CIC
Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BRC
Bell Rock Capital Rehoboth Beach, Delaware $81M AUM 9.85% 1-Year Est. Return
BA
BKS Advisors Southfield, Michigan $249M AUM 14.37% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

Walleye Trading's BIB Position: Q4 2018 in Review

Walleye Trading sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q4 2018, closing a stake of 393 shares — an estimated $27K sold.

Walleye Trading first reported a position in BIB in Q3 2016 and held it in 6 quarters. The position peaked at $27K in Q3 2018. 27 funds tracked by Wall St. Rank hold BIB as of Q4 2018.

  • Walleye Trading reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q4 2018 after selling out during the quarter.
  • Walleye Trading sold 393 ProShares Ultra NASDAQ Biotechnology shares in Q4 2018, an estimated $27K.
  • Walleye Trading first reported a position in ProShares Ultra NASDAQ Biotechnology in Q3 2016 and held it in 6 quarters.
  • Walleye Trading's ProShares Ultra NASDAQ Biotechnology position peaked at $27K in Q3 2018.
  • 27 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q4 2018.

Based on Walleye Trading's 13F filing for Q4 2018, filed 14 Feb 2019.